PMID: 21173337DOI: 10.1001/archdermatol.2010.367Dec 22, 2010

Regional squamous cell carcinomas following systemic sorafenib therapy and isolated limb infusion for regionally advanced metastatic melanoma of the limb

Archives of Dermatology
A RaymondKelly Carter Nelson

Abstract

No abstract listed.

Citations

A phase I multi-institutional study of systemic sorafenib in conjunction with regional melphalan for in-transit melanoma of the extremity

May 3, 2012·Annals of Surgical Oncology·Georgia M BeasleyDouglas S Tyler

(Secondary) solid tumors in thyroid cancer patients treated with the multi-kinase inhibitor sorafenib may present diagnostic challenges

Jan 21, 2016·BMC Cancer·Tatiana C SchneiderHans Morreau

Sorafenib-induced premalignant and malignant skin lesions

Mar 19, 2011·International Journal of Dermatology·Victoria L WilliamsDavid J Stewart

Extensive Squamous Cell Carcinoma of the Skin Related to Use of Sorafenib for Treatment of FLT3-Mutant Acute Myeloid Leukemia

Jul 16, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amir T FathiYi-Bin Chen

Cutaneous reactions to novel therapeutics

Sep 25, 2012·The American Journal of Dermatopathology·Mai P Hoang, Daniela Kroshinsky

Related Concepts

Nexavar
Antineoplastic Agents
Benzenesulfonates
Squamous Cell Carcinoma
Leg
Melanoma
Neoplasm Metastasis
Enduramide
Phenylurea Compounds
Pyridines

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Related Papers

The regressing keratoacanthoma

(opens in new tab)
Histopathology
K BlessingP M Gordon

Array of cutaneous adverse effects associated with sorafenib

(opens in new tab)
Journal of the American Academy of Dermatology
Heidi H Kong, Maria L Turner
ContactHelpTerms Privacy Cookies Blog
© 2021 Meta ULC. All rights reserved